BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 191.00
-2.20 (-1.14%)
Apr 20, 2026, 4:08 PM HKT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of 281.22 billion as of April 20, 2026. Its market cap has increased by 22.08% in one year.
Market Cap
281.22B
Enterprise Value
254.17B
Revenue
41.59B
Ranking
n/a
PE Ratio
125.92
Stock Price
191.00
Market Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 6.70B to 281.22B, an increase of 4,099.32%. That is a compound annual growth rate of 44.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 281.22B | 7.47% |
| Dec 31, 2025 | 261.67B | 71.29% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 158.77B |
| WuXi Biologics | 153.84B |
| Akeso | 139.09B |
| Sichuan Kelun-Biotech Biopharmaceutical | 121.26B |
| Sino Biopharmaceutical | 107.21B |
| RemeGen | 85.82B |
| 3SBio | 63.09B |
| Shanghai Junshi Biosciences | 47.13B |